Physician profile
James M Horowitz
NPI 1831374131
$81,962.23
in general payments reported to CMS, 2019-2025
22 companies · $1,015 in 2025
The $1,015 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,700 · 2020: $31K · 2021: $35K · 2022: $3,290 · 2023: $4,424 · 2024: $581 · 2025: $1,015.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,220 · Food and Beverage: $2,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,219.80 |
| Food and Beverage | $2,799.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $60,846.04 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ambu INC. | $9,089.83 | 2020-2022 | |
| Penumbra, INC. | $4,940.64 | 2019-2025 | Indigo System |
| Abiomed | $3,833.41 | 2019-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,202.18 | 2020-2024 | Lifevest |
| Aop Health US, LLC | $443.24 | 2025 | Rapiblyk |
| Angiodynamics, INC. | $330.31 | 2025 | Alphavac |
| Novartis Pharmaceuticals Corporation | $245.75 | 2020-2024 | |
| Philips North America LLC | $213.11 | 2024 | (2585) 5500 Whc and Poc Ultrasound System, (Ab7) 5500 Series Ultrasound System, (Bv6) 5500 Whc and Poc Ultrasound System |
| Pfizer INC. | $144.29 | 2022-2024 | |
| Vapotherm INC | $129.05 | 2019-2020 | |
| Aidoc Medical LTD | $114.00 | 2023 | Briefcase |
| Amgen INC. | $74.43 | 2022-2024 | Repatha |
| Nuwellis, INC. | $63.76 | 2024 | Aquadex Smartflow Console |
| Janssen Pharmaceuticals, INC | $55.96 | 2021-2024 | Xarelto |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $55.50 | 2019-2024 | Camzyos |
| Boston Scientific Corporation | $48.20 | 2023 | Ekosonic |
| Kestra Medical Technology Services, INC. | $45.37 | 2023 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $36.60 | 2024 | Farxiga |
| Kiniksa Pharmaceuticals International, Plc | $23.00 | 2024 | Arcalyst |
| Atricure, INC. | $14.07 | 2019 | |
| Bardy Diagnostics, INC. | $13.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Horowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.